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Dorsal root ganglion neurons, which express herpes simplex virus (HSV) latency-associated
transcript (LAT) during experimental latent infection, wereinvestigated byin situ hybridization.
The number ofLAT-positive neurons was determined by examination ofganglion serial sections.
In other latently infected mice, the number of ganglion neurons that reactivated HSV antigen
after explant culture was determined in serial sections. LAT was detected in 100 percent of
ganglia, with an average of 19.5 LAT-positive neurons per ganglion. After explant culture of
latently infected ganglia (in the presence of colchicine to decrease spread of reactivated virus),
HSV antigen wasdetected in 94 percentofganglia, withanaverageof 13.1 positive neurons inthe
antigen-positive ganglia. The similar quantities of LAT- and antigen-positive neurons within
ganglia support thehypothesis that LAT-positive neurons were the neurons from which HSV was
reactivated.
Latent herpes simplex virus (HSV) infections occur frequently in neurons of
peripheral nervous system sensory ganglia and are the substrate of recurrent HSV
infections [1]. During latency, HSV deoxyribonucleic acid (DNA) is present in
modified form [2,3], and, although viral proteins are probably not present, HSV-
specified RNA has been detected by nucleic acid hybridization in latently infected
human and experimental animal ganglia [4-10]. In early studies, purified radiolabeled
HSV DNA was used to probe ganglion sections for ribonucleic acid (RNA) [4,5].
More recently, HSV viral RNA present in ganglion tissues has been investigated in
detail by the use ofcloned DNA restriction endonuclease fragments to probe ganglion
tissues [6-11]. Viral RNA detected in ganglia has been termed HSV latency-as-
sociated transcript(s) (LAT) [9,10] or latency-related RNA [11]. LAT partially
overlaps the viral ICP 0 gene but is transcribed from the HSV DNA strand which is
complementary to the strand which encodes the ICP 0 gene [6-1 1].
Although most studies of HSV latency have investigated ganglia of the peripheral
nervous system, HSV latency in central nervous system tissues may also occur. HSV
has been isolated from latently infected tissues ofthe central nervous system, albeit at
lower frequencies than from peripheral nervous system ganglia [12,13]. In some
studies, it has not been possible to isolate HSV from central nervous system tissues
[14,15], although the presence of LAT in these tissues was evident [14]. In addition,
the detection of LAT but the relative lack of reactivable HSV has been noted after
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inoculation of mice with ICP 0 [16] or thymidine kinase [17] mutants of HSV. The
presence of LAT but the relative inability to reactivate infectious HSV raises the
question of whether LAT-positive ganglion neurons are the neurons from which HSV
is reactivated.
In the present study, we quantitated the number ofLAT-positive neurons by serially
sectioning ganglia, followed by in situ hybridization of the sections. In other ganglia,
the number of neurons that expressed HSV antigens after explant cultivation was
determined and compared with the number of LAT-positive neurons. It was hypothe-
sized that, ifLAT-positive neurons were the cells which reactivated HSV, the number
of LAT-positive neurons and antigen-positive neurons would be similar.
MATERIALS AND METHODS
Virus andAnimal Inoculation
The KOS strain ofHSV type 1, obtained from the American type culture collection
and passed multiple times in cell culture [5], was grown and titered bystandard means
in primary rabbit kidney cells. Random-bred six- to eight-week-old male and female
mice (Charles River Laboratories, Inc, Wilmington, MA) were anesthetized and one
drop (approximately 50 Mil) of virus suspension (107 plaque-forming units/ml) was
dropped on to each rear footpad, which was then punctured multiple times with a
needle through the virus drop. By this procedure, greater than 90 percent ofmice were
latently infected with the virus [18] without causing mortality [unpublished observa-
tion]. During the period of HSV latency (28-35 days post-footpad inoculation), mice
were sacrificed, and dorsal rootganglia (DRG) were processed for in situ hybridization
todetect LAT. Alternatively, DRG wereexplanted for fourdays inmediumcontaining
5 percent heat-inactivated bovine serum, and subsequently processed for HSV antigen
detection.
In Situ Hybridization
Lumbar 4 (L4) and L5 DRG were fixed in 3 percent paraformaldehyde and
embedded in paraffin. Serial ten-micron sections were collected on to 3-amino-
propyltriethoxysilane-treated slides. After deparaffinization in xylene and rehydration
in graded ethanols, the slides were sequentially treated with 0.2 N HCI, proteinase K
(5 jg/ml in 10 mM Tris, pH 7.4), 2 mM CaCl2 and 0.25 percent acetic anhydride (in
0.1 M triethanolamine buffer, pH 8.0). Tissue sections were hybridized with 1-3 ng
(approximately 105 cpm) of [35S]-labeled probe DNA. Prior to hybridization, DNA
probes were denatured at 1OQOC for ten minutes, quenched on ice, and resuspended in
sodium chloride-sodium citrate buffer (10 mM Tris, pH 7.4; 1 mM EDTA, Denhardts
solution, 10 percent dextran sulfate, 45 percent formamide), 100,g/ml ofmousebrain
nucleic acids, and 100Mig ofM. luteus DNA. Hybridization was carriedoutat460C for
72 hours. After extensive washing, slides were coated with NTB-3 emulsion (Kodak,
Rochester, NY), exposed for four days at 40C, developed, and stained with hematoxy-
lin.
Probesfor in Situ Hybridization
The EC subfragment ofthe Bam HI E fragment of HSV type 1 (Patton strain) and
multiple other restriction endonuclease fragments were obtained from D.J. Spector
and R.W. Hyman (The Pennsylvania State University College of Medicine). The
restriction endonuclease fragments used are shown in Fig. 1. HSV DNA fragments
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FIG. 1. Map of the HSV-1 genome and the EcoRI and BamHI restriction fragments used for in situ
hybridization. A. The HSV-1 genome in the long segment inverted orientation [23]. The location ofthe
Bam HI B fragment in this orientation and its size in kilobase pairs is indicated. The long unique (UL) and
short unique (U,) regions are bounded by the long terminal repeat (TRL) and short terminal repeat (TRQ)
and by inverted repeats (IRL, IR,). B. Subfragments ofthe Bam HI Efragment showing HpaI sites(H)
and BamHI sites (B) with sizes in kilobase pairs. Diagram is derived from Spector et al. [24]. Positive
hybridization was obtained only with the EC subfragment (solid bar). C. Other restriction fragments
used in hybridization studies which gave negative results.
were isolated from plasmid vectors by electroelution, and 25- to 50-ng amounts were
nick translated at 150C with 60 gg of [35S]dCTP (1,000 Ci/mmol, Amersham).
Unincorporated nucleotides were separated from nick-translated DNA by ethanol
precipitation. Specific activities of [35S]-labeled probes were 1-2 x 108 cpm/,ug.
Explant Culture andAntigen Detection
L4 and L5 DRG were removed and cultured in medium containing 5 percent
heat-inactivated bovine serum for four days. To minimize axonal spread ofreactivated
HSV, which would prevent identification of individual antigen-positive neurons,
colchicine (50 ,g/ml) was added to the explant culture medium. After incubation for
four days, ganglia were washed in saline buffer and fixed in 3 percent paraformalde-
hyde. Following embedding, ten-micron serial paraffin sections were collected on
gelatinized slides. Sections were deparaffinized and further treated with ice-cold
methanol containing 0.5 percent H202. After hydration in phosphate-buffered saline
containing 20 percent horse serum, sections were treated with polyclonal rabbit
anti-HSV serum (1:100, Dako, Santa Barbara, CA). Biotinylated anti-rabbit IgG and
avidin-peroxidase conjugate were added according to manufacturer's directions (Vec-
tor, Burlingame, CA), and sections were then treated with diaminobenzidine (0.25
mg/ml). After washing, sections were dehydrated and mounted.
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CountingHybridization-Positive andAntigen-Positive Neurons
Hybridization-positive neurons, indicating the presence of LAT, were identified by
the presence of clusters of silver grains. In preliminary studies, individual hybridiza-
tion-positive neurons were identified on either a single section or with lesser frequency
on two adjacent sections. Therefore, to estimate the number of hybridization-positive
neurons in DRG, the total number of hybridization-positive cells in sections of a
ganglion was counted and this figure was divided by 1.25 to arrive at a corrected
number ofLAT-positive cells.
Antigen-positive cells were seen on one, two, or three adjacent sections, with most
antigen-positive cells being seen on two sections. Approximately twice as many were
seen on three sections as on one section. Therefore, to estimate the number of
antigen-positive cells, the absolute count was corrected by dividing by 2.5.
To determine proportions of LAT- and antigen-positive neurons within ganglia, we
used 3,500 as an estimate ofthe number ofneurons present in mouse L4 and L5 DRG.
Investigators have recorded varying numbers ofneurons in DRG [19], and 3,500 is an
estimate from our counts in which nucleoli werecounted in serial eight-micron sections
[unpublished results].
RESULTS
LAT was detected in all DRG (13/13) from mice sacrificed 28-35 days after
footpad inoculation of HSV. The number ofLAT-positive neurons ranged from 4-57
per DRG (mean, 19.5; refer to Table 1). Grains were localized over the nuclei of
neurons (Fig. 2), as noted initially with purified HSV DNA probes [5] and more
recently with cloned restriction endonuclease fragment probes [6-9]. Hybridization
was detected only with the BamHI EC subfragment of the E fragment, similar to
results obtained by others using theBamHI B fragment [6-9]. Positive results with the
E fragment would bepredicted since repeat sequences are the same in both theBamHI
B and E fragments, and hybridization has been reported with BamHI subfragments
limited to repeat sequences [9,14]. In this report we considered LAT to be present if
hybridization was detected with the EC subfragment of the BamHI E fragment. The
proportion of LAT-positive neurons in our serial section study with the EC subfrag-
ment ofthe E fragment supported and extended the results obtained byothers with the
BamHI B fragment in which ganglion sections were sampled [6-9].
After explant culture for four days in the presence of colchicine, discrete antigen-
positive neurons were easily recognized (Fig. 3A-E), whereas in cultures without
colchicine the spread of antigen within ganglia was apparent (Fig. 3F). Apparent
axonal spread of HSV and spread to Schwann cells (Fig. 3G) precluded accurate
TABLE 1
LAT-Positive and HSV Antigen-Positive Neurons in Mouse Dorsal Root Ganglia
Number ofPositive Proportion ofPositive
Number ofGanglia Neurons in Positive Neurons in Positive
Positive/Total (%) Ganglia, Mean ± SD Ganglia, Mean (range)'
LAT-positive 13/13 (100) 19.5 ± 16.8 0.006 (.001-.02)
HSV antigen-positiveb 31/33 (94) 13.1 ± 18.5 0.004 (.001-.02)
aProportions were calculated based on an estimate of3,500 neurons perganglion (seetext).
bAfter explant for four days in the presence ofcolchicine, 50,g/ml
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FIG. 2. LAT expression as detected by positive hybridization with the BamHI EC fragment. A.
Low-power photomicrograph showing three LAT-positive neurons. B-D. Higher-power photomicro-
graphs showing a single LAT-positive neuron in only one ofthree serial ten-micron sections.
counting ofcells in which reactivation had occurred. Following colchicine treatment of
explant cultures for four days, HSV antigen was detected in 31/33 (94 percent) of
DRG, and the number of antigen-positive neurons ranged from 0-76 (mean, 12.4;
refer to Table 1). In HSV antigen-positive ganglia, the range of positive neurons was
2-76 (mean, 13.1). The only cells clearly seen to be antigen-positive were large and
small neurons. Estimates of neuron size were arrived at by determination of the
number of ten-micron sections in which peroxidase reaction product was present in
individual neurons; most positive neurons were observed in two adjacent sections.
A comparison of the number of LAT-positive neurons and HSV antigen-positive
neurons is shown in Table 1. Although some differences in the average number of
antigen- and LAT-positive neurons are apparent, there was no significant difference
between the two when neurons from positive ganglia were compared (p > .05).
DISCUSSION
It was hypothesized that if LAT-positive neurons in latently infected ganglia were
the cells from which HSV was reactivated, the number of LAT-positive and antigen-
positive neurons would be similar. Only slight differences between the number of
LAT-positive and antigen-positive neurons were observed, and these are probably
explained by biological variability and by differences in the experimental methodolo-
gies used. Specifically, the number of HSV antigen-positive cells is probably a min-
imum estimate ofthe neurons which reactivated virus.
While the quantities of LAT-positive neurons in ganglia can be considered to be
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FIG. 3. HSV antigen detected after explant cul-
ture of latently infected DRG. A-E. DRG
explanted for four days in medium containing col-
chicine (50 pg/ml), showing neurons expressing
antigen; spread of antigen within the ganglion is
limited. Serial ten-micron sections show two anti-
gen-positive neurons in each of three sec-
tions. F. DRG explanted for four days in
medium without colchicine, showing extensive
spread ofantigen in a ganglion. G. Higher mag-
nification, showing antigen spread in axons and
Schwann cells.
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accurate estimates, those of HSV antigen-positive neurons after ganglion explant
culture are probably underestimates. To count antigen-positive cells accurately after
explant culture, it was necessary to minimize the effect ofHSV spread within explants
following HSV reactivation in latently infected neurons. Therefore, we added colchi-
cine to the reactivation medium, to decrease axonal spread of HSV and to permit
maintenance of explant cultures for four days. Explant cultures without colchicine
permitted the detection ofindividual antigen-positive cells only in cultures of up to two
days. Beyond two days in culture, cell-to-cell spread of HSV was evident, and
quantitation of the number of individual antigen-positive cells was precluded.
Although the use ofcolchicine permitted the evaluation offour-day explant cultures, it
is probable that occasional neurons that could have reactivated virus later were missed.
Therefore, it is likely that the number ofantigen-positive neurons in ganglia is slightly
higher than the estimate in the present study. This underestimation would decrease the
difference between LAT- and antigen-positive neurons. It is also probable that
colchicine inhibited HSV reactivation or subsequent HSV replication within neurons,
to explain partially the relatively low number of antigen-positive cells. In cell culture
studies, colchicine was found to decrease the yield of HSV slightly when low
multiplicities of infection were used, and amounts of HSV in reactivating explant
cultures were also decreased [unpublished observations]. It also remains possible that
some LAT-positive cells were destroyed after explantation, or that for other reasons
not all LAT-positive cells reactivated HSV.
Estimates of the number of neurons reactivating HSV antigen have not been
previously published, although an estimate ofthe number ofHSV-positive neurons was
determined in an infectious center study [20]. The results obtained in the present study
indicated a lesser number of antigen-positive neurons, possibly related to methods of
detection but also probably related to the strain of virus and/or mouse tested. In
addition, we noted large differences in antigen distribution in ganglia, related to the
titer of virus inoculated and whether trigeminal ganglia (after corneal inoculation of
virus) or dorsal root ganglia (after footpad inoculation of virus) were studied
[unpublished observation].
The results of this study support the conclusion that LAT-positive neurons are
probably the cells from which HSV reactivates, although the role of LAT during
latency and its possible relationship to HSV ICP 0 expression remain unclear.
Speculation of an interaction with HSV ICP 0 has centered on possible antisense
inhibition [ 10,1 11 ]. While such a mechanism is possible, the demonstrations that HSV
mutants defective for ICP 0 [16] and for LAT expression [21,22] can establish latent
infections need to be taken into account. In addition, the detection of LAT but the
relative lack of reactivable HSV in central nervous system tissues [14] and after
inoculation with thymidine kinase mutants of HSV [17] suggest that, although
LAT-positive neurons probably reactivate HSV, LAT expression alone is not synony-
mous with HSV latency. LAT expression with limited reactivation of HSV might
indicate abortive or incomplete latency.
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